Annual FCF
-$416.00 M
-$192.44 M-86.08%
December 31, 2023
Summary
- As of February 26, 2025, LEGN annual free cash flow is -$416.00 million, with the most recent change of -$192.44 million (-86.08%) on December 31, 2023.
- During the last 3 years, LEGN annual FCF has fallen by -$162.71 million (-64.24%).
- LEGN annual FCF is now -245.12% below its all-time high of $286.66 million, reached on December 31, 2018.
Performance
LEGN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$77.89 M
-$72.82 M-1436.84%
September 30, 2024
Summary
- As of February 26, 2025, LEGN quarterly free cash flow is -$77.89 million, with the most recent change of -$72.82 million (-1436.84%) on September 30, 2024.
- Over the past year, LEGN quarterly FCF has increased by +$24.61 million (+24.01%).
- LEGN quarterly FCF is now -490.47% below its all-time high of $19.95 million, reached on September 30, 2019.
Performance
LEGN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$176.18 M
-$11.57 M-7.03%
September 30, 2024
Summary
- As of February 26, 2025, LEGN TTM free cash flow is -$176.18 million, with the most recent change of -$11.57 million (-7.03%) on September 30, 2024.
- Over the past year, LEGN TTM FCF has increased by +$239.82 million (+57.65%).
- LEGN TTM FCF is now -663.39% below its all-time high of -$23.08 million, reached on September 30, 2019.
Performance
LEGN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
LEGN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -86.1% | +24.0% | +57.6% |
| 3 y3 years | -64.2% | +24.0% | +57.6% |
| 5 y5 years | -245.1% | +24.0% | +57.6% |
LEGN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.1% | at low | -939.9% | +45.7% | -7.0% | +57.6% |
| 5 y | 5-year | -240.3% | at low | -939.9% | +45.7% | -44.1% | +57.6% |
| alltime | all time | -245.1% | at low | -490.5% | +45.7% | -663.4% | +57.6% |
Legend Biotech Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$77.89 M(+1436.8%) | -$176.18 M(+7.0%) |
| Jun 2024 | - | -$5.07 M(-154.7%) | -$164.61 M(-37.5%) |
| Mar 2024 | - | $9.27 M(-109.0%) | -$263.24 M(-36.7%) |
| Dec 2023 | -$416.00 M(+86.1%) | -$102.49 M(+54.5%) | -$416.00 M(+12.2%) |
| Sep 2023 | - | -$66.32 M(-36.0%) | -$370.77 M(-2.0%) |
| Jun 2023 | - | -$103.69 M(-27.7%) | -$378.22 M(+31.2%) |
| Mar 2023 | - | -$143.49 M(+150.6%) | -$288.36 M(+29.0%) |
| Dec 2022 | -$223.56 M(-8.3%) | -$57.26 M(-22.4%) | -$223.56 M(-5.8%) |
| Sep 2022 | - | -$73.78 M(+433.5%) | -$237.28 M(+7.5%) |
| Jun 2022 | - | -$13.83 M(-82.4%) | -$220.71 M(-25.4%) |
| Mar 2022 | - | -$78.69 M(+10.8%) | -$295.77 M(+21.3%) |
| Dec 2021 | -$243.87 M | -$70.99 M(+24.1%) | -$243.87 M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$57.20 M(-35.6%) | -$225.09 M(-6.0%) |
| Jun 2021 | - | -$88.89 M(+231.8%) | -$239.53 M(+2.2%) |
| Mar 2021 | - | -$26.79 M(-48.7%) | -$234.28 M(-7.5%) |
| Dec 2020 | -$253.29 M(+107.2%) | -$52.21 M(-27.1%) | -$253.29 M(-15.6%) |
| Sep 2020 | - | -$71.65 M(-14.3%) | -$300.24 M(+43.9%) |
| Jun 2020 | - | -$83.64 M(+82.6%) | -$208.64 M(+44.5%) |
| Mar 2020 | - | -$45.80 M(-53.8%) | -$144.34 M(+18.1%) |
| Dec 2019 | -$122.23 M(-142.6%) | -$99.16 M(-597.1%) | -$122.23 M(+429.7%) |
| Sep 2019 | - | $19.95 M(-203.1%) | -$23.08 M(-46.4%) |
| Jun 2019 | - | -$19.34 M(-18.4%) | -$43.02 M(+81.6%) |
| Mar 2019 | - | -$23.69 M | -$23.69 M |
| Dec 2018 | $286.66 M | - | - |
FAQ
- What is Legend Biotech annual free cash flow?
- What is the all time high annual FCF for Legend Biotech?
- What is Legend Biotech annual FCF year-on-year change?
- What is Legend Biotech quarterly free cash flow?
- What is the all time high quarterly FCF for Legend Biotech?
- What is Legend Biotech quarterly FCF year-on-year change?
- What is Legend Biotech TTM free cash flow?
- What is the all time high TTM FCF for Legend Biotech?
- What is Legend Biotech TTM FCF year-on-year change?
What is Legend Biotech annual free cash flow?
The current annual FCF of LEGN is -$416.00 M
What is the all time high annual FCF for Legend Biotech?
Legend Biotech all-time high annual free cash flow is $286.66 M
What is Legend Biotech annual FCF year-on-year change?
Over the past year, LEGN annual free cash flow has changed by -$192.44 M (-86.08%)
What is Legend Biotech quarterly free cash flow?
The current quarterly FCF of LEGN is -$77.89 M
What is the all time high quarterly FCF for Legend Biotech?
Legend Biotech all-time high quarterly free cash flow is $19.95 M
What is Legend Biotech quarterly FCF year-on-year change?
Over the past year, LEGN quarterly free cash flow has changed by +$24.61 M (+24.01%)
What is Legend Biotech TTM free cash flow?
The current TTM FCF of LEGN is -$176.18 M
What is the all time high TTM FCF for Legend Biotech?
Legend Biotech all-time high TTM free cash flow is -$23.08 M
What is Legend Biotech TTM FCF year-on-year change?
Over the past year, LEGN TTM free cash flow has changed by +$239.82 M (+57.65%)